Role of high-flow nasal oxygen therapy in COVID-19 pneumonia with Eisenmenger syndrome: A case report

Muhammad Rafiqi Hehsan; Ahmad Dzarrin Hanafi; Huda Zainal Abidin; Wan Fadzlina Wan Shukeri; Kamaruddin Ibrahim; Laila Abdul Mukmin

doi:10.1016/j.ijcchd.2022.100325

Role of high-flow nasal oxygen therapy in COVID-19 pneumonia with Eisenmenger syndrome: A case report

Int J Cardiol Congenit Heart Dis. 2022 Mar:7:100325. doi: 10.1016/j.ijcchd.2022.100325. Epub 2022 Jan 12.

Authors

Muhammad Rafiqi Hehsan^{1

2}, Ahmad Dzarrin Hanafi¹, Huda Zainal Abidin¹, Wan Fadzlina Wan Shukeri¹, Kamaruddin Ibrahim¹, Laila Abdul Mukmin¹

Affiliations

¹ Department of Anesthesiology and Intensive Care, Universiti Sains Malaysia, School of Medical Sciences, 16150, Kubang Kerian, Kelantan, Malaysia.
² Faculty of Medicine and Health Sciences, Islamic Science University of Malaysia, Bandar Baru Nilai, 71800, Nilai, Negeri Sembilan, Malaysia.

Abstract

Since the coronavirus disease 2019 (COVID-19) pandemic emerged in November 2019, various international guidelines and local protocols have been published to assist clinicians face the pandemic effectively. Medical and ventilatory strategies have evolved and researchers have come out with multiple studies and solutions within a short period of time. The patient's best interest is always the goal of the management. We present a case report of COVID-19 pneumonia in a patient with underlying Eisenmenger syndrome and the potential benefits of high-flow nasal oxygen therapy in this patient.

Keywords: Atrial septal defect, ASD; COVID-19; Congenital heart disease; Congenital heart disease, CHD; Eisenmenger syndrome; High flow nasal oxygen therapy; High flow nasal oxygen therapy, HFNOT.

Publication types

Case Reports